Add like
Add dislike
Add to saved papers

Predictive factors associated with the visual prognosis after surgery for idiopathic vitreomacular traction.

Retina 2023 October 27
PURPOSE: To investigate the predictive factors for post-surgical visual prognosis in vitreomacular traction (VMT) patients.

METHODS: This retrospective study enrolled 31 eyes from 29 patients who underwent vitrectomy for idiopathic VMT with follow-up period ≥ 3 months. The VMT was divided into three grades based on optical coherence tomography images: grade 1 denoted partial vitreomacular separation with foveal attachment; grade 2 exhibited intraretinal cysts or cleft with grade 1 findings; grade 3 was grade 2 plus the subretinal fluid.

RESULTS: Three eyes developed a full-thickness macular hole after surgery, all of which were grade 3 patients. In the rest 28 eyes, the mean postoperative follow-up period was 23.3 ± 25.8 months. The postoperative central foveal thickness (P=0.001) and final best-corrected visual acuity (BCVA; P<0.001) were both significantly improved from baseline. Fifteen eyes (53.8%) gained ≥ two Snellen lines. Multilinear regression analysis showed that the worse the baseline BCVA (P=0.004), or the more advanced the VMT grade (P=0.049), the worse the final BCVA. Baseline BCVA was negatively associated with the postoperative visual improvement (P<0.001). Those grade 3 patients with baseline Snellen BCVA ≥ 20/40 were more likely to achieve a final Snellen BCVA ≥ 20/25 (P=0.035).

CONCLUSION: The VMT grade is an important predictive factor for the post-surgical visual prognosis. Surgical intervention should be performed as early as possible for grade 3 patients to prevent further disease progression and maximize the post-surgical visual benefit.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app